Not available
Quote | Bellerophon Therapeutics Inc. (NASDAQ:BLPH)
Last: | $0.1025 |
---|---|
Change Percent: | 21.34% |
Open: | $0.303 |
Close: | $0.1025 |
High: | $0.303 |
Low: | $0.076 |
Volume: | 13,605,115 |
Last Trade Date Time: | 10/13/2023 03:00:00 am |
News | Bellerophon Therapeutics Inc. (NASDAQ:BLPH)
China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Message Board Posts | Bellerophon Therapeutics Inc. (NASDAQ:BLPH)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $BLPH 20% v1,1M c10.75 f10,448M H11.88 ML1.73 RL7.92 what a push | znewcar1 | investorshangout | 04/04/2023 8:37:52 PM |
whytestocks: $BLPH News Article - Bellerophon Provides Clinical Program Update and Reports Full-Year | whytestocks | investorshangout | 03/31/2023 6:50:52 PM |
Its got to be relatively low with those | dinogreeves | investorshub | 03/20/2023 7:14:23 PM |
Lol one needs a flashlight to find the | eur06 | investorshub | 03/20/2023 6:03:40 PM |
Cricket and frog.. lol | dinogreeves | investorshub | 03/20/2023 5:55:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Bellerophon Therapeutics Inc. Company Name:
BLPH Stock Symbol:
NASDAQ Market:
Bellerophon Therapeutics Inc. Website:
China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Bellerophon Therapeutics Inc. (BLPH) is expected to report for Q3 2023